Aegerion Pharmaceuticals, Inc. - Boston, United States - FDA Site Report

FEI Number: 3009569098

Overview Statistics

Total Inspections

Total 483s Issued

Warning Letters Issued

25.0%

483 Issue Rate

Last Inspected: 2022-09-14

Discover the bigger picture. This is just the tip of the iceberg.

Gain access to comprehensive analysis, detailed reports, AI assistant, and much more.

Date	Investigators	Category	Days
2022-09-14	Michael Serrano	Human Drugs	3 days
2020-01-23	Matthew C Watson John L Zaccone	Human Drugs	8 days
2015-07-16	Mary-Jeanet Mcgarry John P Mistler	Human Drugs	10 days
2012-08-27	Alan R Condon Matthew C Watson	-	-

Last Updated: 2025-05-14 06:13:20